1Imai, K & Nakachi, K (1995) Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 310, 693–696.
2Sasazuki, S, Kodama, H, Yoshimasu, K, et al. (2000) Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol 10, 401–408.
3Kuriyama, S, Shimazu, T, Ohmor, K, et al. (2006) Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296, 1255–1265.
4Nakachi, K, Matsuyama, S, Miyake, S, et al. (2000) Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 13, 49–54.
5Wang, QM, Gong, QY, Yan, JJ, et al. (2010) Association between green tea intake and coronary artery disease in a Chinese population. Circ J 74, 294–300.
6Jochmann, N, Lorenz, M, Krosigk, A, et al. (2008) The efficacy of black tea in ameliorating endothelial function is equivalent to that of green tea. Br J Nutr 99, 863–868.
7Widlansky, ME, Hamburg, NM, Anter, E, et al. (2007) Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr 26, 95–102.
8Nagaya, N, Yamamoto, H, Uematsu, M, et al. (2004) Green tea reverses endothelial dysfunction in healthy smokers. Heart 90, 1485–1486.
9Alexopoulos, N, Vlachopoulos, C, Aznaouridis, K, et al. (2008) The acute effect of green tea consumption on endothelial function in healthy individuals. Eur J Cardiovasc Prev Rehabil 15, 300–305.
10Lorenz, M, Wessler, S, Follmann, E, et al. (2004) A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem 279, 6190–6195.
11Ludwig, A, Lorenz, M, Grimbo, N, et al. (2004) The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochem Biophys Res Commun 316, 659–665.
12Yamakuchi, M, Bao, C, Ferlito, M, et al. (2008) Epigallocatechin gallate inhibits endothelial exocytosis. Biol Chem 389, 935–941.
13Kim, JA, Formoso, G, Li, Y, et al. (2007) Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem 282, 13736–13745.
14Steffen, Y, Gruber, C, Schewe, T, et al. (2008) Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys 469, 209–219.
15Hodgson, JM, Puddey, IB, Burke, V, et al. (2006) Is reversal of endothelial dysfunction by tea related to flavonoid metabolism? Br J Nutr 95, 14–17.
16Chen, J, Lipska, BK, Halim, N, et al. (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75, 807–821.
17Shield, AJ, Thomae, BA, Eckloff, BW, et al. (2004) Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Mol Psychiatry 9, 151–160.
18Boudikova, B, Szumlanski, C, Maidak, B, et al. (1990) Human liver catechol-O-methyltransferase pharmacogenetics. Clin Pharmacol Ther 48, 381–389.
19Tunbridge, EM, Harrison, PJ & Weinberger, DR (2006) Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 60, 141–151.
20Dawling, S, Roodi, N, Mernaugh, RL, et al. (2001) Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res 61, 6716–6722.
21Montag, C, Buckholtz, JW, Hartmann, P, et al. (2008) COMT genetic variation affects fear processing: psychophysiological evidence. Behav Neurosci 122, 901–909.
22Chow, HHS, Hakim, IA, Vining, DR, et al. (2005) Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals. Clin Cancer Res 11, 4627–4633.
23Chow, HHS, Cai, Y, Hakim, IA, et al. (2003) Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 9, 3312–3319.
24Armah, CK, Jackson, KG, Doman, I, et al. (2008) Fish oil fatty acids improve postprandial vascular reactivity in healthy men. Clin Sci (Lond) 114, 679–686.
25Henning, SA, Niu, Y, Liu, Y, et al. (2005) Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals. J Nutr Biochem 16, 610–616.
26Lee, MJ, Maliakal, P, Chen, LS, et al. (2002) Pharmacokinetics of tea catechins after ingestion of green tea and ( − )-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 11, 1025–1032.
27Chow, HHS, Cai, Y, Alberts, DS, et al. (2001) Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev 10, 53–58.
28Steffen, Y, Schewe, T & Sies, H (2007) ( − )-Epicatechin elevates nitric oxide in endothelial cells via inhibition of NADPH oxidase. Biochem Biophys Res Commun 359, 828–833.
29Padilla, JM, Berjano, EJ, Saiz, J, et al. (2009) Pulse wave velocity and digital volume pulse as indirect estimators of blood pressure: pilot study on healthy volunteers. Cardiovasc Eng 9, 104–112.
30Hagen, K, Pettersen, E, Stovner, LJ, et al. (2007) High systolic blood pressure is associated with Val/Val genotype in the catechol-o-methyltransferase gene. The Nord-Trondelag Health Study (HUNT). Am J Hypertens 20, 21–26.
31Stewart, SH, Oroszi, G, Randall, PK, et al. (2009) COMT genotype influences the effect of alcohol on blood pressure: results from the COMBINE study. Am J Hypertens 22, 87–91.
32Masuda, M, Tsunoda, M & Imai, K (2006) Low catechol-O-methyltransferase activity in the brain and blood pressure regulation. Biol Pharm Bull 29, 202–205.
33Domschke, K & Dannlowski, U (2010) Imaging genetics of anxiety disorders. Neuroimage 53, 822–831.
34Wu, LY, Juan, CC, Ho, LT, et al. (2004) Effect of green tea supplementation on insulin sensitivity in Sprague–Dawley rats. J Agric Food Chem 52, 643–648.
35Wolfram, S, Raederstorff, D, Preller, M, et al. (2006) Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr 136, 2512–2518.
36Potenza, MA, Marasciulo, FL, Tarquinio, M, et al. (2007) EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292, E1378–E1387.
37Brown, AL, Lane, J, Coverly, J, et al. (2008) Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr 101, 886–894.
38Ryu, OH, Lee, J, Lee, KW, et al. (2006) Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 71, 356–358.
39Fukino, Y, Ikeda, A, Maruyama, K, et al. (2008) Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr 62, 953–960.
40Venables, MC, Hulston, CJ, Cox, HR, et al. (2008) Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. Am J Clin Nutr 87, 778–784.
41Law, WS, Huang, PY, Ong, ES, et al. (2008) Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy. Rapid Commun Mass Spectrom 22, 2436–2446.
42Kring, SI, Werge, T, Holst, C, et al. (2009) Polymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetes. PLoS One 4, e6696.